Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 224

    True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

    True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

    Medical Dialogues Bureau21 Oct 2018 12:01 PM IST
    Mumbai: Merck Consumer Health India - a leader in Vitamin E in India - announced the publication of the country’s first handbook that highlights the...
    Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

    Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

    Medical Dialogues Bureau21 Oct 2018 11:01 AM IST
    New Delhi: Jubilant Cadista Pharmaceuticals Inc, is recalling over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets manufactured by...
    FDA snubs Novartis bid to repurpose inflammation drug canakinumab for heart attacks

    FDA snubs Novartis bid to repurpose inflammation drug canakinumab for heart attacks

    Medical Dialogues Bureau21 Oct 2018 10:01 AM IST
    In trials for heart disease, Novartis discovered a potential benefit in lung cancer patients for the drug, prompting the company to start cancer...
    Takeda gets Japans approval for $62 billion Shire purchase

    Takeda gets Japan's approval for $62 billion Shire purchase

    Medical Dialogues Bureau21 Oct 2018 9:27 AM IST
    Takeda Pharmaceutical Co Ltd. said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the...
    Shires drug Takhzyro for rare swelling disorder wins European panel green light

    Shire's drug Takhzyro for rare swelling disorder wins European panel green light

    Medical Dialogues Bureau21 Oct 2018 9:01 AM IST
    A European Medicines Agency(EMA) panel on Friday recommended approving a potential blockbuster drug from Shire Plc to treat patients aged 12 and older...
    Dengue vaccine should be approved: European Medicines Agency

    Dengue vaccine should be approved: European Medicines Agency

    Medical Dialogues Bureau20 Oct 2018 3:03 PM IST
    LONDON - Europe's medicines regulator has recommended the approval of the first vaccine for dengue despite concerns about the vaccine's wide use and a...
    Sanofi drug Dupixent wins USFDA approval to treat asthma

    Sanofi drug Dupixent wins USFDA approval to treat asthma

    Medical Dialogues Bureau20 Oct 2018 12:32 PM IST
    France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in...
    Maryland asks Supreme Court to uphold law on drug pricing

    Maryland asks Supreme Court to uphold law on drug pricing

    Medical Dialogues Bureau20 Oct 2018 12:32 PM IST
    ANNAPOLIS, Md.: Maryland Attorney General Brian Frosh petitioned the U.S. Supreme Court on Friday to uphold a first-in-the-nation law against...
    Zydus Cadila gets USFDA nod for generic gout attacks drug- Colchicine

    Zydus Cadila gets USFDA nod for generic gout attacks drug- Colchicine

    Medical Dialogues Bureau20 Oct 2018 12:30 PM IST
    The tablets, "will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad," it said.New Delhi: Drug firm Zydus Cadila...
    Novartis to buy cancer drugmaker Endocyte for $2.1 Billion in cash

    Novartis to buy cancer drugmaker Endocyte for $2.1 Billion in cash

    Medical Dialogues Bureau20 Oct 2018 9:18 AM IST
    Novartis AG will acquire U.S. based cancer drugmaker Endocyte Inc for $2.1 billion in cash as the Swiss drugmaker expands its radio pharmaceuticals...
    Zydus Cadila gets USFDA nod to market Clobetasol Propionate cream for skin treatment

    Zydus Cadila gets USFDA nod to market Clobetasol Propionate cream for skin treatment

    Medical Dialogues Bureau19 Oct 2018 10:51 AM IST
    New Delhi: Drug firm Zydus Cadila Wednesday said it has received final nod from the US health regulator to market generic Clobetasol Propionate cream,...
    Samsung launches third rival to AbbVies Humira drug in EU

    Samsung launches third rival to AbbVie's Humira drug in EU

    Medical Dialogues Bureau19 Oct 2018 9:20 AM IST
    LONDON: South Korea's Samsung Bioepis and its partner Biogen have launched a third rival to AbbVie's blockbuster medicine Humira in Europe, ramping up...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok